Molina Healthcare director Dale Wolf sells $329,792 in shares

Dale B. Wolf, a director at Molina Healthcare, sold 1,600 shares of the company's common stock on November 13, 2026, for a total of $329,792. The shares were bought and sold at prices between $206.05 and $206.33, averaging $206.12 per share. This move comes as Molina Healthcare's stock has seen a significant rise, increasing by over 52% in the last year.

As of now, the stock is trading at $209.49, although InvestingPro indicates the stock is still potentially undervalued. After the sale, Mr. Wolf indirectly holds 14,337 shares through the Dale B. Wolf Revocable Trust, of which he is the sole trustee. Molina Healthcare also reported robust earnings for the third quarter of 2026, with adjusted earnings per share of $0.89, beating analyst expectations of $0.79.

The company's revenue for the quarter was $11.08 billion, outperforming the forecasted $10.86 billion. Despite these strong results, the company did not increase its full-year guidance. Molina Healthcare's stock has received positive ratings from analysts, with Bernstein and Mizuho assigning an Outperform rating and price targets of $266.00 and $255.00, respectively.

Other analysts, like Jefferies and Cantor Fitzgerald, have also maintained their ratings but with different price targets. The company's medical loss ratio stands at 92.9%, a slight increase from the previous year's 92.6%. Investors are also keeping an eye on potential cost pressures from a new Florida contract and a softer revenue outlook for 2027.